Syntax Bio
Programming new cell therapies using CRISPR-based technology.
Biotechnology
📍 Chicago, IL
Founded 2026
Current Valuation
Private
PRIVATE
Programming new cell therapies using CRISPR-based technology. Headquartered in Chicago, IL. Raised $14.4M in Series A funding in June 2026 led by Astellas Venture Management.
Company Profile
Last Round
Series A — $14M (Jun 2026) · Lead: Astellas Venture Management
Fundraising Status
Series A · $14M · this month
privateTotal raised $25M1 disclosed rounds
Funding History
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Series A | $14M | Jun 2026 | Astellas Venture Management | — |
Founders & Key People
Doug DoerflerPete Bodine
Investors
Astellas Venture Management · Illumina Ventures · DCVC Bio · Civilization Ventures · EGB Capital · Mansueto Office · Portal Innovations · Draper Associates · Allegis Capital · LongGame · Mayo Clinic · Illinois Ventures
BiotechnologySynthetic BiologyRecently Funded
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.